Great analysis Stewie...er, I mean AZ. As I've said often enough (ad nauseum) I am not a science guy, but you validated my opinion of today's "news"

"However, at this point in the development of RVX-208, any more of simple science news on RVX-208 is all fluff...."

I couldn't agree more...I hate the word "may" in a press release. It strikes me as an effort to pump the share price. To wit:

"Selective BET inhibition via RVX-208 may represent a novel approach to CKD treatment....."

This didn't strike me as anything material in nature that warranted disclosure.